1
Orphan Designations
0 approved, 1 designated
0
FDA Approvals
0
Active Trials
1
Rare Diseases
across 2 areas
0
News (30d)
Quiet
Twinpig Biolab, Inc. is a company with 1 orphan drug designation across 1 rare disease.
Disease-by-disease pipeline progression from orphan designation through clinical trials to FDA approval.
Source: FDA Orphan Drug Designations, ClinicalTrials.gov, Drugs@FDA
| Disease | Drug(s) | Stage |
|---|---|---|
| hepatocellular carcinoma | {PEG2}-Val1-Leu2-Thr3-Thr4-Gly5-Leu6-Pro7-Ala8-Leu9-Ile10Ser11Trp12-Ile13- Lys14Arg15-Lys16-Arg17-Gln18-Gln19-Gly20-Gly21-Gly22-Gly23-Ser24-dLys25-dLeu26- | Des.TrialAppr. |
0% of portfolio targets high unmet need diseases
0
overlap in 2+ diseases
0/1
candidate diseases
0
avg importance: 0
0
affecting portfolio
0% of portfolio targets high unmet need diseases
0
overlap in 2+ diseases
0/1
candidate diseases
0
avg importance: 0
0
affecting portfolio